Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Bruce Jancin

    News

    Post-MI beta-blockers: Less is more

    Author:
    Bruce Jancin
    Publish date: April 14, 2014

    Major finding: Patients discharged post MI on a beta-blocker at roughly 25% of the target dose – which was established as conferring a survival...

    • Read More

    News

    ACC/AHA cardiovascular risk equations get a thumbs-up

    Author:
    Bruce Jancin
    Publish date: April 14, 2014

    Major finding: The controversial cardiovascular risk equations at the heart of the latest ACC/AHA risk-assessment guidelines turned in a moderate...

    • Read More

    News

    ACC/AHA Cardiovascular Risk Equations Get a Thumbs-up

    Author:
    Bruce Jancin
    Publish date: April 14, 2014

    Major finding: The controversial cardiovascular risk equations at the heart of the latest ACC/AHA risk-assessment guidelines turned in a moderate...

    • Read More

    News

    Crushing ticagrelor tablets sped platelet inhibition

    Author:
    Bruce Jancin
    Publish date: April 11, 2014

    Major finding: Mean plasma concentration of ticagralor was roughly fivefold greater 30 minutes post dose via a crushed tablet in water vs.

    • Read More

    News

    Ultrasound-facilitated endovascular thrombolysis 'a game changer' in acute pulmonary embolism

    Author:
    Bruce Jancin
    Publish date: April 10, 2014

    Major finding: Ultrasound-facilitated, catheter-directed, low-dose fibrinolysis in patients with high-risk pulmonary embolism improved right...

    • Read More

    News

    Off-label use of novel anticoagulants accelerates

    Author:
    Bruce Jancin
    Publish date: April 10, 2014

    Major finding: By the fourth quarter of 2012, 14.9% of patients with nonvalvular AF were on a novel anticoagulant. So were 13.8% of those with...

    • Read More

    News

    'Favorable signal' for secondary coronary prevention in STABILITY

    Author:
    Bruce Jancin
    Publish date: April 8, 2014

    Major finding: The combined rate of cardiovascular death, myocardial infarction, or stroke in patients randomized to darapladib was 9.7%, yielding...

    • Read More

    News

    Antipsychotics’ risk in dementia revised upward

    Author:
    Bruce Jancin
    Publish date: April 8, 2014

    Major finding: Among elderly patients with dementia placed on an antipsychotic to treat behavioral problems, the number needed to harm – that is,...

    • Read More

    News

    Asenapine often beneficial in geriatric bipolar disorder

    Author:
    Bruce Jancin
    Publish date: April 7, 2014

    Major finding: The atypical antipsychotic asenapine produced significant improvement in symptoms and mood in patients with later-life bipolar...

    • Read More

    News

    VIDEO: PCSK9 inhibitors placed in perspective

    Author:
    Bruce Jancin
    Publish date: April 7, 2014

    • Read More

    News

    Apixaban provides larger medical cost savings than other NOACs

    Author:
    Bruce Jancin
    Publish date: April 4, 2014

    Major finding: Using apixaban instead of warfarin for stroke prevention in AF would result in an estimated medical cost savings of $1,245 per...

    • Read More

    News

    Key studies show distinctive features of pediatric psoriasis

    Author:
    Bruce Jancin
    Publish date: April 1, 2014

    • Read More

    News

    Surprising new findings about late-life schizophrenia

    Author:
    Bruce Jancin
    Publish date: March 31, 2014

    Major finding: Quality of life in older persons with schizophrenia changed significantly either for better or for worse over the course of 52...

    • Read More

    News

    ECT electrode placement matters most in elderly

    Author:
    Bruce Jancin
    Publish date: March 31, 2014

    Major finding: Right unilateral ECT provided a 70.4% remission rate in severely depressed patients aged 60 or older, compared with a 46% rate in...

    • Read More

    News

    Evolocumab betters ezetimibe for lowering LDL in statin-intolerant patients

    Author:
    Bruce Jancin
    Publish date: March 31, 2014

    Major finding: Statin-intolerant patients with hypercholesterolemia experienced mean 53%-56% reductions in LDL cholesterol in response to 12 weeks...

    • Read More

    Pages

    • « first
    • …
    • 121
    • 122
    • 123
    • 124
    • 125
    • 126
    • 127
    • 128
    • 129
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery